Late stent thrombosis: Considerations and practical advice for the use of drug-eluting stents: A report from the Society for Cardiovascular Angiography and Interventions drug-eluting stent task force (original) (raw)

Abstract

sparkles

AI

This report from the Society for Cardiovascular Angiography and Interventions addresses the rising concerns regarding late stent thrombosis associated with drug-eluting stents (DES) compared to bare metal stents. It highlights the increased incidence of this complication, particularly after 30 days of stent implantation, and emphasizes the importance of adhering to dual antiplatelet therapy to mitigate risks. The report also summarizes key patient and lesion characteristics linked to heightened risk of stent thrombosis and provides practical guidelines for interventional cardiologists.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (17)

  1. Pfisterer M, Brunner-La Rocca HP, Buser PT, Rickenbacher P, Hunziker P, Mueller C, Jeger R, Bader F, Osswald S, Kaiser C, for the BASKET-LATE investigators. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents. J Am Coll Cardiol 2006;48:2584-2591.
  2. Camenzind E. Safety of drug-eluting stents: Insights from meta analysis. Available at www.escardio.org/knowledge/congresses/ congressreports/hotlinesandctus/707009_Camenzind.htm Accessed December 13, 2006.
  3. Nordmann AJ, Briel M, Bucher HC. Mortality in randomized controlled clinical trials comparing drug-eluting vs. bare metal stents in coronary artery disease: A meta analysis. Eur Heart J 2006;27:2784-2814.
  4. Leon MB, Stone GW. Presentation at TCT October 25, 2006. Available at www.tctmd.com/csportal/appmanager/tctmd/main?\_ nfpb¼true&_pageLabel¼TCTMDContent&hdCon¼1453648. Accessed December 13, 2006.
  5. Serruys P. Presentation at the European Congress of Cardiology in Barcelona (September 2006). Discussed in Clappers and Ver- heugt. Hotline sessions of the 28th European Congress of Cardi- ology/World Congress of Cardiology. Eur Heart J 2006;27: 2896-2899.
  6. Bavry AA, Kumbhant DJ, Helton TJ, Borek PP, Mood GR, Bhatt DL. Late thrombosis of drug-eluting stents: A meta-analysis of randomized clinical trials. Am J Med 2006;119:1056-1061.
  7. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R. Pathology of drug- eluting stents in humans: Delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193-202.
  8. Cutlip D. Presented at TCT on October 25, 2006. Available at www.medscape.com/viewarticle/546575\. Accessed December 13, 2006.
  9. Chen M, John J, Chew D, Lee D, Ellis S, Bhatt D. Bare metal stent restenosis is not a benign clinical entity. Am Heart J 2006; 151:1260-1264.
  10. Spertus JA, Kettelkamp R, Vance C, Decker C, Jones PG, Rumsfeld JS, Messenger JC, Khanal S, Peterson ED, Bach RG, Krumholz HM, Cohen DJ. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: Results from the PREMIER regis- try. Circulation 2006;113:2803-2809.
  11. Eisenstein EL, Anstrom KJ, Kong DF, Shaw LK, Tuttle RH, Mark DB, Kramer JM, Harrington RA, Matchar DB, Kandzari DE, Peterson ED, Schulman KA, Califf RM. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implan- tation. JAMA 2006, Dec 5; [epub ahead of print].
  12. Nguyen TA, Diodati JG, Pharand C. Reisitance to clopidogrel: A review of the evidence. J Am Coll Cardiol 2005;45:1157-1164.
  13. Michos ED, Ardehali R, Blumenthal RS, Lange RA, Ardehali H. Aspirin and clopidogrel resistance. Mayo Clin Proc 2006;81: 518-26.
  14. Smith SC Jr, Feldman TE, Hirshfield JW Jr, Jacobs AK, Kern MJ, King SB III, Morrison DA, O'Neill WW, Schaff HV, Whitlow PL, Williams DO. ACC/AHA/SCAI 2005 guideline update for percuta- neous coronary intervention: A report of the American College of Cardiology/ American Heart Associan Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 Guidelines for Percutaneous Coronary Intrervention) American College of Cardiology Web Site. Available at www. acc.org/clinical/guidelines/percutaneous/update/index_rev.pdf
  15. Nishioka T, Amanullah AM, Luo HUAI. Clinical validation of intravascular ultrasound imaging for assessment of coronary ste- nosis severity: Comparison with stress myocardial perfusion imaging. J Am Coll Cardiol 1999;33:1870-1878.
  16. Costa MA. Impact of stent deployment techniques on long-term clinical outcomes of patients treated with sirolimus-eluting stents. Presentation at TCT 10-2006. Incidence of geographical miss in patients treated with sirolimus-eluting stents: Insights from the STLLR trial. Am J Cardiol 2004;94(suppl 6A):206E.
  17. Ellis SG, Bajzer CT, Bhatt DL, Brener SJ, Whitlow PL, Lincoff AM, Moliterno DJ, Raymond RE, Tuzcu EM, Franco I, Dush- man-Ellis S, Lander KJ, Schneider JP, Topol EJ. Real-world bare metal stenting: Identification of patients at low or very low risk of 9-month coronary revascularization. Catheter Cardiovasc Interv 2004;63:135-140.